Join us in Paris
to study the recent and rapid advances in the treatment of hepatitis C that have completely changed the scenario of this disease over the past months.
It is not always easy to keep up-to-date in this fast changing field due to the huge amount of data coming from a vast number of published studies, but we’ll do our best to keep you informed.
The outbreak of obesity, metabolic syndrome, and diabetes has driven NAFLD as a top cause of liver disease.
Management of NAFLD in clinical practice is surrounded by uncertainties and clinical dilemmas that motivate us to explore them beyond the borders of hepatology.
There is still time to register
||We’re calling EASL members to propose program proposals and topics that you wish to see on the educational calendar in the coming months.
Have you discovered a subject in your practice or research that you think should be covered by EASL? We strongly encourage you to submit your idea and, if approved, EASL will assist you in the development and presentation of your topic.
Read more on the EASL website
The EASL Monothematic Conference on Liver Fibrosis: the next goal of targeted therapy? in Porto, in June, will begin with a session entitled ‘Shaping liver fibrosis: the impact of etiology, genetic and epigenetic factors’.
Discover the scientific programme and register online now to benefit from reduced fees.
Content is now available from ILC 2016. Discover the webcast sessions, learning quizzes, video postcast, ePosters, abstracts and more on the EASL LiverTree, our educational e-platform!
Join the EASL community to enjoy this membership benefit!